Still room for more

Still room for more

Therapy Description Status Company Partner(s)
Rituxan (IDEC-C2B8) Chimeric MAb against CD20 antigen on B

Read the full 185 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE